Biblio

Export 3292 results:
Author Title Type [ Year(Asc)]
Filters: Filter is   [Clear All Filters]
2024
A. M. R. McLaren and Kawaja, M. D., Olfactory Dysfunction and Alzheimer's Disease: A Review., J Alzheimers Dis, vol. 99, no. 3, pp. 811-827, 2024.
R. A. Mace, Lyons, C., Cohen, J. E., Ritchie, C., Bartels, S., Okereke, O. I., Hoeppner, B. B., Brewer, J. A., and Vranceanu, A. - M., Optimizing the Implementation of a Lifestyle Dementia Prevention Intervention for Older Patients in an Academic Healthcare System., J Alzheimers Dis, vol. 100, no. 4, pp. 1237-1259, 2024.
J. Maters, van der Steen, J. T., de Vugt, M. E., Bakker, C., and Koopmans, R. T. C. M., Palliative Care in Nursing Home Residents with Young-Onset Dementia: Professional and Family Caregiver Perspectives., J Alzheimers Dis, vol. 97, no. 2, pp. 573-586, 2024.
A. S. Buchman, Yu, L., Oveisgharan, S., Zammit, A. R., Wang, T., Shulman, J. M., VanderHorst, V., Nag, S., and Bennett, D. A., Parkinson's Disease and Other Alzheimer's Disease and Related Dementia Pathologies and the Progression of Parkinsonism in Older Adults., J Alzheimers Dis, vol. 100, no. s1, pp. S197-S209, 2024.
X. Morató, Tartari, J. Pablo, Pytel, V., and Boada, M., Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer's Disease., J Alzheimers Dis, vol. 101, no. s1, pp. S285-S298, 2024.
B. Zeng, Tang, C., Wang, J., Yang, Q., Ren, Q., and Liu, X., Pharmacologic and Nutritional Interventions for Early Alzheimer's Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials., J Alzheimers Dis, vol. 99, no. 4, pp. 1173-1186, 2024.
X. Huang, Wang, J., Zhang, S., Zhao, X., An, R., Lan, Y., Yi, M., and Wan, Q., Plasma BDNF/Irisin Ratio Associates with Cognitive Function in Older People., J Alzheimers Dis, vol. 99, no. 4, pp. 1261-1271, 2024.
J. M. Chandler, Ye, W., Mi, X., Doty, E. G., and Johnston, J. A., Potential Impact of Slowing Disease Progression in Early Symptomatic Alzheimer's Disease on Patient Quality of Life, Caregiver Time, and Total Societal Costs: Estimates Based on Findings from GERAS-US Study., J Alzheimers Dis, vol. 100, no. 2, pp. 563-578, 2024.
L. Zuo, Hu, Y., Dong, Y. H., Seet, R. Cs, Li, Z., Wang, Y., and Zhao, X., Pre-existing dementia is associated with 2-3 folds risk for in-hospital mortality and complications after intracerebral hemorrhage stroke., J Alzheimers Dis, vol. 102, no. 2, pp. 338-346, 2024.
H. Kim, Le, B., Goshi, N., Zhu, K., Grodzki, A. Cristina, Lein, P. J., Zhao, M., and Seker, E., Primary cortical cell tri-culture to study effects of amyloid-β on microglia function and neuroinflammatory response., J Alzheimers Dis, vol. 102, no. 3, pp. 730-741, 2024.
C. Cressot, Vrillon, A., Lilamand, M., Francisque, H., Méauzoone, A., Hourregue, C., Dumurgier, J., Marlinge, E., Paquet, C., and Cognat, E., Psychosis in Neurodegenerative Dementias: A Systematic Comparative Review., J Alzheimers Dis, vol. 99, no. 1, pp. 85-99, 2024.
O. Snytnikova, Telegina, D., Savina, E., Tsentalovich, Y., and Kolosova, N., Quantitative Metabolomic Analysis of the Rat Hippocampus: Effects of Age and of the Development of Alzheimer's Disease-Like Pathology., J Alzheimers Dis, vol. 99, no. s2, pp. S327-S344, 2024.
A. J. Espay, Herrup, K., Imbimbo, B. P., Kepp, K. P., and Daly, T., Recalibrating the Risk-Benefit Profiles of Lecanemab and Donanemab: Scales, Immunoreactivity, and Changes in Amyloid-β42., J Alzheimers Dis, vol. 99, no. 3, pp. 877-881, 2024.
P. Sachdeva, Narayanan, K. Badri, Sinha, J. Kumar, Gupta, S., Ghosh, S., Singh, K. Kumar, Bhaskar, R., Almutary, A. G., Zothantluanga, J. H., Kotta, K. Kumar, Nelson, V. Kumar, Paiva-Santos, A. Cláudia, Abomughaid, M. Mohammad, Kamal, M., Iqbal, D., ALHarbi, M. Hamoud, ALMutairi, A. Aedh, Dewanjee, S., Nuli, M. Vamsi, Vippamakula, S., Jha, S. Kumar, Ojha, S., and Jha, N. Kumar, Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease., J Alzheimers Dis, vol. 98, no. 4, pp. 1169-1179, 2024.
K. Ishii, Yamada, T., Hanaoka, K., Kaida, H., Kojita, Y., Kono, A., Hanada, K., Saigoh, K., Sakuta, S., Hashimoto, M., Kato, T., and Nakamura, A., Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain., J Alzheimers Dis, vol. 102, no. 1, pp. 228-236, 2024.
H. Stevens Smith, Robinson, J. O., Levchenko, A., Pereira, S., Pascual, B., Bradbury, K., Arbones, V., Fong, J., Shulman, J. M., McGuire, A. L., and Masdeu, J., Research Participants' Perspectives on Precision Diagnostics for Alzheimer's Disease., J Alzheimers Dis, vol. 97, no. 3, pp. 1261-1274, 2024.
C. Marr, McDowell, B., Holmes, C., Edwards, C. J., Cardwell, C., McHenry, M., Meenagh, G., Teeling, J. L., and McGuinness, B., The RESIST Study: Examining Cognitive Change in Rheumatoid Arthritis Patients with Mild Cognitive Impairment Being Treated with a TNF-Inhibitor Compared to a Conventional Synthetic Disease-Modifying Anti-Rheumatic Drug., J Alzheimers Dis, vol. 99, no. 1, pp. 161-175, 2024.
Y. Okinaka, Shinagawa, Y., Claussen, C., Gul, S., Matsui, I., Matsui, Y., and Taguchi, A., RNA Analysis of Circulating Leukocytes in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 97, no. 4, pp. 1673-1683, 2024.
M. Safieh, Liraz, O., Ovadia, M., and Michaelson, D., The Role of Impaired Receptor Trafficking in Mediating the Pathological Effects of APOE4 in Alzheimer's Disease., J Alzheimers Dis, vol. 97, no. 2, pp. 753-775, 2024.
G. Alva, Cubała, W. J., Berrio, A., Coate, B., Abler, V., and Pathak, S., Safety Profile of Pimavanserin Therapy in Elderly Patients with Neurodegenerative Disease-Related Neuropsychiatric Symptoms: A Phase 3B Study., J Alzheimers Dis, vol. 98, no. 1, pp. 265-274, 2024.
S. Duchesne, Rousseau, L. - S., Belzile-Marsolais, F., Welch, L. - A., Cournoyer, B., Arseneau, M., Lapierre, V., Poulin, S. - M., Potvin, O., and Hudon, C., A Scoping Review of Alzheimers Disease Hypotheses: An Array of Uni- and Multi-Factorial Theories., J Alzheimers Dis, vol. 99, no. 3, pp. 843-856, 2024.
P. Y. Ng, Zhang, C., Li, H., and Baker, D. J., Senescence Targeting Methods Impact Alzheimer's Disease Features in 3xTg Mice., J Alzheimers Dis, vol. 97, no. 4, pp. 1751-1763, 2024.
F. H. Duits, Nilsson, J., Zetterberg, H., Blennow, K., van der Flier, W. M., Teunissen, C. E., and Brinkmalm, A., Serial Cerebrospinal Fluid Sampling Reveals Trajectories of Potential Synaptic Biomarkers in Early Stages of Alzheimer's Disease., J Alzheimers Dis, vol. 100, no. s1, pp. S103-S114, 2024.
C. E. Johnson, Duncan, M. J., and M Murphy, P., Sex and Sleep Disruption as Contributing Factors in Alzheimer's Disease., J Alzheimers Dis, vol. 97, no. 1, pp. 31-74, 2024.
K. Duff, Hammers, D. B., Koppelmans, V., King, J. B., and Hoffman, J. M., Short-Term Practice Effects on Cognitive Tests Across the Late Life Cognitive Spectrum and How They Compare to Biomarkers of Alzheimer's Disease., J Alzheimers Dis, vol. 99, no. 1, pp. 321-332, 2024.

Pages